UPDATE: Incyte Meets 3Q Estimates, Revenues Up 47 Percent | GenomeWeb

NEW YORK, Oct 17 – Genomic information company Incyte Genomics reported Tuesday third quarter net losses of $7.6 million, or 12 cents per diluted share, compared with a net loss of $11.1 million, or 20 cents per diluted share, for the same period a year ago, meeting Wall Street expectations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.